Impact of Rivastigmine Use on the Risk of Nursing Home Placement in a US Sample

ISSN： 1172-7047

Source： CNS Drugs, Vol.18, Iss.15, 2004-01, pp. : 1143-1148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Rivastigmine on Caregiver Burden Associated with Alzheimer's Disease in Both Informal Care and Nursing Home Settings

By Grossberg George T.

Drugs & Aging, Vol. 25, Iss. 7, 2008-01 ,pp. : 573-584

Adis International

Access to resources Recommend Favorite

Use of Antipsychotics among Elderly Nursing Home Residents with Dementia in the US: An Analysis of National Survey Data

By Kamble Pravin Chen Hua Sherer Jeffrey T. Aparasu Rajender R.

Drugs & Aging, Vol. 26, Iss. 6, 2009-06 ,pp. : 483-492

Adis International

Access to resources Recommend Favorite

Risk of Antipsychotic Drug Use in Patients with Alzheimers Disease Treated with Rivastigmine

By Suh D-C.

Drugs & Aging, Vol. 21, Iss. 6, 2004-01 ,pp. : 395-403

Adis International

Access to resources Recommend Favorite

Long-Term Effects of Rivastigmine Treatment on the Need for Psychotropic Medications in Nursing Home Patients with Alzheimers Disease: Results of a 52-Week Open-Label Study

By Edwards Keith

Clinical Drug Investigation, Vol. 25, Iss. 8, 2005-01 ,pp. : 507-515

Adis International

Access to resources Recommend Favorite

Alendronic acid: giving US nursing-home residents a break

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 346, 2002-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite